# Dermatology

- [Atopic dermatitis](/content/dermatology/atopic-dermatitis/index.html)
- [Psoriasis](/content/dermatology/psoriasis/index.html)
- [Actinic keratosis](/content/dermatology/actinic-keratosis/index.html)
- [Acne](/content/dermatology/acne/index.html)
- Other skin conditions
  - [Onychomycosis](/content/dermatology/onychomycosis/index.html)
  - [Alopecia areata](/content/dermatology/alopecia-areata/index.html)
  - [Keratinocyte cancer](/content/dermatology/keratinocyte-cancer/index.html)
  - [Vitiligo](/content/dermatology/vitiligo/index.html)
  - [Hidradenitis suppurativa](/content/dermatology/hidradenitis-suppurativa/index.html)
  - [Rare skin diseases](/content/dermatology/rare-skin-diseases/index.html)

# Analyst coverage

## Analysts

Almirall, S.A. is followed by the analysts listed below:

- **Alantra**  
  *Alvaro Lenze*  
  T+34 915 508 714

- **Banco Santander**  
  *Jaime Escribano*  
  T+34 912 890 258

- **CaixaBank**  
  *Guilherme Macedo Sampaio*  
  T+35 122 607 3179

- **Deutsche Bank**  
  *Emmanuel Papadakis*  
  T+44 207 541 8522

- **Fidentiis Equities**  
  *Patricia Cifuentes*  
  T+34 915 662 458

- **Jefferies International Ltd**  
  *Shan Hama / Lucy Cordrington*  
  T+44 (0)20 7548 / 4084

- **Renta 4 Banco**  
  *Álvaro Aristegui Echevarría*  
  T+34 913 848 587

- **Stifel**  
  *Damien Choplain*  
  T+33 6 30 56 03 50

- **Banco Sabadell**  
  *Luis Arredondo*  
  T+34 913 217 257

- **Bankinter**  
  *Pedro Echeguren*  
  T+34 917 941 031

- **UBS**  
  *Jo Walton*  
  T+44 207 567 4596

- **Exane BNP Paribas**  
  *Francisco Ruiz Martín*  
  T+34 911 148 306

- **JB Capital Markets, S. V.**  
  *Joaquín García-Quirós*  
  T+34 91 794 05 16

- **Kepler/Cheuvreux**  
  *Pablo de Renteria*  
  T+34 91 436 5221

- **Oddo BHF**  
  *Juan Ros-Padilla*  
  T+34 660 415 071

*Please note that any opinions, estimates, or forecasts regarding the performance of Almirall, S.A. made by these analysts are theirs alone and do not represent opinions, forecasts, or predictions held at Almirall, S.A., nor by its management. Almirall, S.A. does not, by referring to or distributing the above, imply its endorsement or concurrence with such information, conclusions, or recommendations.*